Many studies previously identified that paired box gene 1 (PAX1), a methylation-silenced gene observed in cervical cancer, can be used as an auxiliary biomarker for clinical examination of cervical cancer to improve the effectiveness of screening [8, 9]. This evidence concerns the gene PAX1 and cervical carcinoma.